New Delhi, Oct. 28 -- The Supreme Court on Tuesday questioned the Centre over its failure to bring all medicines under price control, asking why economic interests should weigh over citizens' lives and why pharmaceutical companies should be allowed to charge high prices for essential drugs. Reserving its order on two petitions challenging high medicine prices, the bench questioned the wide gap between the maximum retail price (MRP) and the price to retailer (PTR). P10...